MedTrace Logo

Embo Registry; National Registry for Artery Embolization

NCT06477965 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-10-28

No results posted yet for this study

Summary

Embo Registry is a retrospective and prospective observational study to evaluate real world effectiveness and the use of Artery Embolization as a treatment for chronic pain with patients that have osteoarthritis and localized pain to provide symptomatic relief. This study is to determine the efficacy and validity of procedure and that following procedure patients had decreased pain and improved quality of life.

Conditions

  • Chronic Pain
  • Osteoarthritis, Knee
  • Osteoarthritis Thumb
  • Osteoarthritis Shoulder
  • Pain, Chronic
  • Tendonitis Elbow
  • Tendonitis Shoulder
  • Tendonitis;Achilles
  • Tenosynovitis

Interventions

PROCEDURE

Artery Embolization

Embolic Solution are intended for use in occluding blood vessels for therapeutic or operative purposes. The embolic solution is used during an outpatient procedure, the physician will insert a small catheter onto the artery supplying the lining of the target joint or target localized pain. Tiny particles are then injected through the catheter into these arteries, reducing blood flow to the target area. This reduces the amount of inflammation associated with osteoarthritis, tendonitis, tenosynovitis or an injury, a process that can help decrease symptoms or eliminate the associated localized pain to this area. With understanding that it does not treat the underlying cartilage destruction or underlying condition causing pain but would like to determine the efficacy and validity of this treatment.

Sponsors & Collaborators

  • Vascular Solutions of North Carolina

    lead OTHER

Principal Investigators

  • Siddhartha Rao, MD · Vascular Solutions of North Carolina

  • Amer Iqbal · Vascular Solutions of North Carolina

  • Meaghan Thomas, CCRP · Vascular Solutions of North Carolina

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-15
Primary Completion
2027-07-15
Completion
2029-07-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06477965 on ClinicalTrials.gov